These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 25526039)

  • 21. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis.
    Sun G; Meng J; Duan H; Zhang D; Tang Y
    Pathol Oncol Res; 2019 Oct; 25(4):1525-1534. PubMed ID: 30488278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma levels of methylated septin 9 are capable of detecting hepatocellular carcinoma and hepatic cirrhosis.
    He N; Feng G; Zhang C; Wu F; Zhang T; Yang Y
    Mol Med Rep; 2020 Oct; 22(4):2705-2714. PubMed ID: 32945374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
    Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
    Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of
    Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
    BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis.
    Song L; Yu H; Jia J; Li Y
    Cancer Biomark; 2017; 18(4):425-432. PubMed ID: 28128742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China.
    Gao JJ; Wang YW; Li Y; Wang ZL; Feng A; Li N; Hui LY
    Clin Chim Acta; 2022 Dec; 537():118-126. PubMed ID: 36330944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylated
    Hitchins MP; Vogelaar IP; Brennan K; Haraldsdottir S; Zhou N; Martin B; Alvarez R; Yuan X; Kim S; Guindi M; Hendifar AE; Kalady MF; DeVecchio J; Church JM; de la Chapelle A; Hampel H; Pearlman R; Christensen M; Snyder C; Lanspa SJ; Haile RW; Lynch HT
    BMJ Open Gastroenterol; 2019; 6(1):e000299. PubMed ID: 31275589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer.
    Church TR; Wandell M; Lofton-Day C; Mongin SJ; Burger M; Payne SR; Castaños-Vélez E; Blumenstein BA; Rösch T; Osborn N; Snover D; Day RW; Ransohoff DF;
    Gut; 2014 Feb; 63(2):317-25. PubMed ID: 23408352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients.
    Jiang H; Yu Q; Chen X; Zhang C; Shen J; Shen M; Yang Y; Wang B; Pan B; Guo W
    J Clin Lab Anal; 2021 Nov; 35(11):e24030. PubMed ID: 34591323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
    Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
    BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
    Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
    Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CAHM, a long non-coding RNA gene hypermethylated in colorectal neoplasia.
    Pedersen SK; Mitchell SM; Graham LD; McEvoy A; Thomas ML; Baker RT; Ross JP; Xu ZZ; Ho T; LaPointe LC; Young GP; Molloy PL
    Epigenetics; 2014 Aug; 9(8):1071-82. PubMed ID: 24799664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening.
    Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M
    Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of droplet digital polymerase chain reaction of plasma methylated septin 9 on detection and early monitoring of colorectal cancer.
    Ma ZY; Chan CSY; Lau KS; Ng L; Cheng YY; Leung WK
    Sci Rep; 2021 Dec; 11(1):23446. PubMed ID: 34873218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
    Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
    Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer.
    Yuan Z; Wang S; Ni K; Zhan Y; Ma H; Liu X; Xin R; Zhou X; Liu Z; Zhao X; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Cui W; Zhang X; Zhang Q; Zhang C
    Med Sci Monit; 2022 Sep; 28():e937757. PubMed ID: 36117308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma methylated septin 9: a colorectal cancer screening marker.
    Molnár B; Tóth K; Barták BK; Tulassay Z
    Expert Rev Mol Diagn; 2015 Feb; 15(2):171-84. PubMed ID: 25429690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Different Blood Collection Tubes and Blood Storage Conditions for the Preservation and Stability of Cell-Free Circulating DNA for the Analysis of the Methylated
    Distler J; Tetzner R; Weiss G; König T; Schlegel A; Bagrowski M
    Adv Exp Med Biol; 2016; 924():175-178. PubMed ID: 27753040
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Semaan A; van Ellen A; Meller S; Bergheim D; Branchi V; Lingohr P; Goltz D; Kalff JC; Kristiansen G; Matthaei H; Pantelis D; Dietrich D
    Clin Epigenetics; 2016; 8():100. PubMed ID: 27660666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
    Bedin C; Enzo MV; Del Bianco P; Pucciarelli S; Nitti D; Agostini M
    Int J Cancer; 2017 Apr; 140(8):1888-1898. PubMed ID: 27943272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.